Research discussion is not a recommendation. Do not buy or use unauthorized products, including products labelled “research use only” or “not for human consumption.”

What it is

GHK-Cu is a copper-binding tripeptide found naturally in human plasma and studied in cell signalling, wound biology, and skin-related research. It also appears as an ingredient in some topical cosmetic formulations.

Route and product matter

Evidence or regulatory treatment for a topical cosmetic ingredient cannot be transferred to an injectable vial. Cosmetics, drugs, and natural health products follow different Canadian rules, and a product’s intended use and claims affect how it is classified.

Canadian context

Health Canada’s 2026 advisory lists injectable GHK-Cu among examples of unauthorized injectable peptide drugs. That warning should not be misread as a blanket statement about every cosmetic containing a copper peptide; it is a reminder to check the exact finished product, route, claims, and regulatory category.

Key unknowns

Online injectable claims often exceed the available controlled human evidence. Unauthorized injectables add product-quality and sterility risks that a cosmetic or laboratory study cannot resolve.

Source trail

Primary sources

  1. Health Canada - 2026 injectable peptide advisory
  2. Health Canada - Cosmetics overview
  3. Health Canada - Drug Product Database
Status can change. Check Health Canada’s Drug Product Database and the exact finished product before relying on this profile. This page is general education, not medical advice or a product recommendation. Full disclaimer.